Impairment of Dilator Responses of Cerebral Arterioles During Diabetes Mellitus
- 1 August 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (8) , 2129-2133
- https://doi.org/10.1161/01.str.0000231654.79017.df
Abstract
Background and Purpose—During diabetes, expression of inducible nitric oxide synthase (iNOS) plays an important role in the development of endothelial dysfunction in extracranial blood vessels. Progression of vascular dysfunction after the onset of diabetes differs among vascular beds. In this study, the effects of hyperglycemia/diabetes on vasomotor function were examined in cerebral arterioles at 2 different times in control and iNOS-deficient mice and compared with the effects on carotid arteries.Methods—Streptozotocin (150 mg/kg IP) was given to induce diabetes. The diameter of cerebral arterioles was measured through a cranial window in diabetic and nondiabetic mice in vivo. Vasomotor function of the carotid artery was examined in vitro.Results—In diabetic mice, responses of the cerebral arterioles to acetylcholine (1 μmol/L) were normal after 3 weeks of diabetes but were significantly impaired after 5 to 6 weeks of diabetes (4±1% [mean±SEM] increase in diameter) compared with control mice (14±1;P=0.0002). Responses to sodium nitroprusside were similar in diabetic and nondiabetic mice at both time points. In contrast, the vasomotor function of the carotid artery was not affected after 5 to 6 weeks of diabetes. In diabetic iNOS-deficient mice, cerebral arteriolar vasomotor function was not impaired, even after 4 months of diabetes.Conclusions—During diabetes, endothelial dysfunction of cerebral arterioles requires expression of iNOS and develops earlier than in carotid arteries.Keywords
This publication has 32 references indexed in Scilit:
- Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- NAD(P)H Oxidases in Rat Basilar Arterial Endothelial CellsStroke, 2005
- Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetesCardiovascular Research, 2004
- Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathwayKidney International, 2004
- Gene-Targeted Mice Reveal a Critical Role for Inducible Nitric Oxide Synthase in Vascular Dysfunction During DiabetesStroke, 2003
- Anti‐inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthaseThe FASEB Journal, 2002
- Effect of Advanced Glycosylation End Products on the Induction of Nitric Oxide Synthase in Murine MacrophagesBiochemical and Biophysical Research Communications, 1996
- Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.Journal of Clinical Investigation, 1991
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987